<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35381027</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>4</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Characterisation of the long-term physical and mental health consequences of SARS-CoV-2 infection: A systematic review and meta-analysis protocol.</ArticleTitle><Pagination><StartPage>e0266232</StartPage><MedlinePgn>e0266232</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0266232</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0266232</ELocationID><Abstract><AbstractText Label="BACKGROUND">As of July 2021, there has been more than 185 million documented cases of the novel coronavirus (SARS-CoV-2) infections and more than 4 million deaths globally. Despite more than 90% of documented cases being classified as "recovered" from SARS-CoV-2 infection, a proportion of patients reported a wide variety of persisting symptoms after the initial onset or acute phase of the infection, often referred to as "Long Covid". As data on the symptomatology of post-acute SARS-CoV-2 infection gradually becomes available, there is an urgent need to organise and synthesise the data in order to define what constitutes Long Covid and assist with its management in clinical and community settings.</AbstractText><AbstractText Label="METHODS">This protocol follows the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) guidelines. A comprehensive literature search strategy will be developed in accordance with the Cochrane highly sensitive search guidelines. The following electronic databases will be searched for studies to include in the systematic review and meta-analysis: MEDLINE (via PubMed), Scopus, Google Scholar, Web of Science (Web of Knowledge), Science direct, EMBASE, Mednar, Psych INFO, and EBSCOhost. Dual screening will be applied at every screening stage. Two reviewers will independently screen titles, abstracts and full text of potentially eligible studies following the predefined inclusion and exclusion criteria in order to select studies to include in the review. As heterogeneity is anticipated between the included studies, data will be pooled in a meta-analysis using a random effects model. A clustering analytic approach will be applied to identify symptoms groupings and assign the symptoms into clusters. R statistical software will be used for the meta-analysis. Highly heterogenous data will be synthesised narratively. The studies will be assessed, for quality using quality assessment tools appropriate for each study design. Two reviewers will independently undertake the quality of studies assessments.</AbstractText><AbstractText Label="DISSEMINATION PLANS">Findings of the systematic review will be disseminated through a peer-reviewed publication and presentation of findings at conferences, workshops and government and private sector stakeholder engagement meetings.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">PROSPERO registration number: CRD4202126589. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD4202126589.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuodi</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2483-3499</Identifier><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorelik</LastName><ForeName>Yanay</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edelstein</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>17</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35381027</ArticleId><ArticleId IdType="pmc">PMC8982872</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0266232</ArticleId><ArticleId IdType="pii">PONE-D-21-25002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. [cited 2021 Jul 11]. https://covid19.who.int/.</Citation></Reference><Reference><Citation>Del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA&#x2014;J Am Med Assoc. 2020. Nov 3;324(17):1723&#x2013;4. doi: 10.1001/jama.2020.19719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannan A, Mannan Baig A. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol [Internet]. 2021. [cited 2021 Jul 12];93:2555&#x2013;6. Available from: doi: 10.1002/jmv.26624</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E, Callard F, Stras L, Melville-J&#xf3;hannesson B, Pope R, Alwan NA. Why the Patient-Made Term &#x201c;Long Covid&#x201d; is needed. Wellcome Open Res 2020 5224 [Internet]. 2020. 
Sep
24 [cited 2021 Jul 12];5:224. Available from: https://wellcomeopenresearch.org/articles/5-224.</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, Court CA&#x2019;, Buxton M, Husain L. Management of post-acute covid-19 in primary care. doi: 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Le&#xf3;n S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al.. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. SSRN Electron J [Internet]. 2021. 
Feb
6 [cited 2021 Jul 25]; Available from: https://papers.ssrn.com/abstract=3769978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep [Internet]. 2020. 
Jul
31 [cited 2021 Jul 12];69(30):993&#x2013;8. Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6930e1.htm. </Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA&#x2014;J Am Med Assoc. 2020. Aug 11;324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al.. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 2020. 
Nov
1 [cited 2021 Jul 12];5(11):1265&#x2013;73. Available from: https://jamanetwork.com/journals/jamacardiology/fullarticle/2768916
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y miao, Shang Y min, Song W bin, Li Q quan, Xie H, Xu Q fu, et al.. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020. Aug 1;25. doi: 10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al.. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ [Internet]. 2015. 
Jan
2 [cited 2021 Jul 13];349. Available from: https://www.bmj.com/content/349/bmj.g7647. </Citation><ArticleIdList><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al.. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev 2012 11 [Internet]. 2012. 
Feb
9 [cited 2021 Jul 13];1(1):1&#x2013;9. Available from: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/2046-4053-1-2. </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-1-2</ArticleId><ArticleId IdType="pmc">PMC3348673</ArticleId><ArticleId IdType="pubmed">22587842</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre C, Manheimer E, Glanville J. Searching for studies. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane B Ser. 2008;95&#x2013;150.</Citation></Reference><Reference><Citation>O&#x2019;Connor D, Green S, Higgins JPT. Defining the review question and developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane B Ser. 2008;81&#x2013;94.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, Sterne JAC. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org. 2011.</Citation></Reference><Reference><Citation>Goldet G, Howick J. Understanding GRADE: an introduction. J Evidence-Based Med. 2013;6(1):50&#x2013;4. doi: 10.1111/jebm.12018</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jebm.12018</ArticleId><ArticleId IdType="pubmed">23557528</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp L. Stata statistical software: Release 15 (2017). Coll Station TX: StataCorp LP. 2019.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>